The app, called Rejoyn, was developed by Otsuka America Pharmaceutical for patients 22 and older who are on antidepressant medication, according to an April 1 company news release. The app is a six-week treatment program to enhance cognitive control of emotion through combined cognitive emotional training exercise and brief therapeutic lessons. It is intended to reduce depression symptoms.
The app is meant to be used alongside medication and talk therapy and requires a prescription by a healthcare professional, the release said.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
